We performed clinical trials concerning efficacy of some antiepileptic drugs in therapy of asthma, and we established high antiasthmatic activity of some antiepileptic drugs (carbamazepine, oxcarbazepine, phenytoin, etc). We suppose that anticonvulsants suppress neurogenic inflammation in airways. Antiinflammatory activity of these drugs is well-known in therapy of neurogenic inflammatory paroxysmal disorders migraine and trigeminal neuralgia.
We consider bronchial asthma as neurogenic inflammatory paroxysmal disorder. For additional information see our website: asthma.ge
We are glad to receive comments from scientists which have interest in neurogenic aspects of asthma and in exploring of new ways of asthma pharmacotherapy.